Now showing items 1-1 of 1
Development of Prodrug Approaches for Long-Acting Injectable Nanoformulations of Emtricitabine-Based Regimens
(Johns Hopkins University, 2018-08-27)
Most current antiretroviral (ARV) medications for HIV treatment and prevention necessitate lifelong daily dosing, and require high levels of patient adherence to be effective. Long-acting injectable (LAI) ARVs would allow ...